Noom
$3.7Bpaper valuation
// OVERVIEW
Noom is a weight loss app that convinced venture capital it was a digital health platform, raised $540 million at a $3.7 billion valuation, then discovered that subscription businesses built on guilt and New Year's resolutions have terrible unit economics when the guilt wears off in February.
// HQ
New York, United States
// STATUS
PRIVATE
// FOUNDED
2008
// TIER
The Unicorn Herd · $1B – $9.9B
// PRIMARY SECTOR
digital health
// FOUNDERS
// FUNDING ROUNDS
// SECTORS SERVED
// TECHNOLOGY
The core product is a calorie tracking app wrapped in behavioral psychology prompts and daily check-ins with human coaches who handle 50+ clients simultaneously. The 'AI' is a recommendation engine that suggests articles about portion control and sends push notifications about water intake.
// WOWLS ASSESSMENT
Noom generated approximately $400 million in revenue in 2021 at peak pandemic home confinement, then watched monthly active users fall 30% as gyms reopened and Ozempic entered the conversation. The company delayed its 2022 IPO indefinitely after filing confidential S-1 paperwork, which is Wall Street code for 'the numbers do not work anymore.' Customer acquisition cost for weight loss apps averages $150-200 while annual customer lifetime value sits around $180-220 — Noom operates in a category where profitable growth requires either retention rates that defy human nature or advertising efficiency that defies mathematics. WeightWatchers tried the app pivot, lost 80% of its market cap, and is now selling Ozempic prescriptions through telehealth — which is the actual digital health business Noom is competing with and losing to.
// WHY WOWLS HUNTS THIS
A $3.7 billion valuation on a subscription app where 70% of users cancel within 90 days and the remaining 30% are one Wegovy prescription away from never opening the app again.
// VALUATION NOTE
Peak valuation of $3.7B from May 2021 Series F. No subsequent rounds or updated valuation disclosed despite confidential IPO filing in 2022 — strongly suggests internal valuation has declined materially.
VERDICT: TERMINAL HYPE — NOOM RAISED $540 MILLION SOLVING A PROBLEM THAT OZEMPIC MADE OBSOLETE FOR $936 PER YEAR
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// BROADCAST INTEL
// SIMILAR TARGETS
// INTEL UPDATED: MAY 2026
// INTELLIGENCE DISCLAIMER: Assessments represent editorial opinion based on publicly available data including filings, press reports, and market data as of the date shown. Valuations are approximate. Not financial or investment advice.
// FULL NETWORK ACCESS
🚀 Founder Briefing: Instantly sort investors by Sector, Stage, & Round — direct links to websites for all 1,030 unicorns & backing VCs included.
Don't just track Noom.
Master the entire 1,030 unicorn company intelligence network.
Stop analyzing tech monopolies one page at a time. Instantly filter, sort, and isolate the exact venture capital firms, angel investors, and corporate funds backing your specific market vertical. Find investors that fit your sector and deploy your pitch with direct outbound links to every target asset in the database — 1,030 targets total.
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// ENGAGE THE FULL ARSENAL
Done reading on Noom?
Unlock the entire 1,030-company hitlist and 1,030 investor contacts.
Full structural breakdowns. Founder dossiers. VC outreach data. Threat-level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN